DOCSLIB.ORG

Comparison of Phencyclidine and Related Substances with Various Indole, Phenethylamine, and Other Psychotomimetics

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Comparison of Phencyclidine and Related Substances with Various Indole, Phenethylamine, and Other Psychotomimetics VOL ZZ, NO, i), reee 973 Comparison of Phencyclidine and chemical subtypes include PCP-like com- pounds, dioxalanes, benzomorphans, and un- Related Substances With Various bridged and bridged benz(f)isoquinolines, all Indole, Phenethylamine, and Other of which have been called "phencyclinoids" Psychotomimetics 1,2 and/or "sigma" opioids (for SKF 10,047). Substances with other heterocyclic structures also produce psychotomimetic effects in- Edward F. Domino, M.D.3 cluding 6) cannabinoids like ~9-THC, the ac- tive ingredient in marijuana, 7) ~-carbolines like harmine and harmaline, 8) some of the constituents of nutmeg including myristic in Introduction and elemicin, and 9) catatonic producing Psychotomimetics are logically classified on agents such as bulbocapnine. the basis of chemical structure. They include: l~ Indolealkyla~ines such as tryptamine, Prototypic Chemical Structures of Various dimethyltryptamine (DMT), 5-methoxydi- Substances Showing PCP-Like Activity methyl tryptamine (5-MeODMT), psilocin, etc. 2) Lysergic acid amides (also called As mentioned above, a number of chemi- lysergimides) such as lysergic acid diethyl- cals with different molecular structures have amide-25 (LSD-25) or LSD for short. LSD PCP-like effects. All of these have been test- cont~ins an indol~ structure and is frequently ed in animals. Only some of these have been classlfi,ed as an mdole hallucinogen. How- v~rified to be si!llilar in man. The compounds ever, Its more complex chemical structure WIth prototypIC structures include those warrants a separate classification. Further- shown in Figure 1. An important chemical more, it is much more difficult to synthesize pr,oblem is to establish the absolute configur- and therefore to obtain illicitly. 3) Some of anon of all of these substances to determine the, p~enethylamines, including amphet- the common elements shared with PCP itself. amme-hke compounds (amphetamine, p- T~ ma~e matters, even more complex, PCP methoxyamphetamine, methamphetamine), exists in four different conformations as and mescaline-like compounds [mescaline, 2, shown in Figure 2. 5-dimethoxy-4-methy lamphetamine (DOM), This has prompted Kamenka (1983) to use methylenedioxyamphetamine (MDA)]. 4) In- the term "chameleon" in describing the PCP frequ~ntly abused are. the M-cholinergic an- molecule and its four different conforma- tag(j~lsts such as atropine and 3-quinuclidinyl tions. Which is the active conformation in the benzilate (QNB). The latter is also known as PCP receptor complex? BZ and at one time was proposed as a chemi- cal warfare agent to induce a psychotomimet- ic s~ate.. 5) Still. another class of psycho- Mechanism of Action of Psychotomimetic torrumeuc agents ISthe arylcyclohexylamines Agents such as phencyclidine (PCP). At least five An important book which summarizes some of our knowledge on the neurochemi- 'Supported in part by NIDA grant DA 01531, cal, behavioral, and clinical perspectives of 2Presented as part of the Panel on Mechanisms of Action of ha!lucinogens is t~at edited by Jacobs (1984). Indole and Phenalkylamine Hallucinogens, December 13, With so many diverse chemical classes of 1985, ACNP Meetings, Maui, HI. 3Department of Pharmacology, University of Michigan, Ann psychotomimetics, there is no simple unifying Arbor, M148109-0010, theory as to how ,they act. .Most investigators Address all correspondence concerning this manuscript to: feel th~t ~he m~Jor cherr~.lCalmessengers in Dr, E.~, Domino, Department of Pharmacology, M6414 Medi- the ~ram mcludmg n<:>repmephrine(NE), ?O- cal SCienceBldg, I, Ann Arbor, M148109-0010, pamme (DA), serotonm (5-HT), acetylchohne - - -. - - ----- / 974 PSYCHOPHARMACOLOGY BULLETIN On the other hand, other phenethylamines such as mescaline, DaM, and various in- dolealkylamine and lysergic acid amides, ap- pear to involve the chemical messenger 5- HT. The newer developments in this field Phencvc i Ld Lne (PCI') nexoxedro I relate to the subtypes of 5-HT receptors. CH, Ligand binding assays using in vitro brain fI- :-':,-CH":!-CH ~_,",_l?,"'membrane fractions from animals are now widely used by neuroscientists. LSD-25 binds to both 5-HTI and 5-HT2 receptors as do ol h- f.eN] ~ 110 some nonhallucinogenic ergot analogs like elll lisuride. However, almost all of these two N~Allylnurr.letazocin e (SH 10.0:'7) cve raacc tne classes of hallucinogens seem to interact more on 5-HT2 sites (Peroutka & Snyder, cs- ,",-C/"'- 1983; Shannon et al., 1984). Shannon et al. ' (1984) used radiolabeled 3H-5-HT and 3H_ CH3 ketanserin to label 5-HT1 and 5-HT2 sites, respectively. They found that among the va- I "" rious hallucinogens studied (especially 110 j}--::;::: phenethylamine derivatives which can be fur- flrid<>."d BE'n:df)isnquin,,;ine9 Bcnz I f ) i5v'1uinolIJw~ ther subclassified as phenisopropylamines) that radioactive binding was more stereo- FIGURE 1. Chemical structures of various com- selective to 5-HT 2than 5-HT 1 sites. Further- pounds that have phencyclidine-like activity. more, the 5-HT2 binding affinities (called K, values) of those hallucinogens correlated with rat behavioral discriminative data (effective (ACh), and some excitatory amino acids like dose 50 percent or ED50s). In turn, these glutamate, in particular, N-methylaspartate correlated with the potencies of some of (NMA), are involved. The two catechol- these compounds as hallucinogens in man. amines, DA and NE, along with the trace About 20 years ago, it was discovered that brain amines phenethylamine and phenetha- animals, when properly trained, discriminate nolamine, appear to be most implicated with the effects of drugs. Ho et al. (1978), Col- stimulant-induced psychoses such as those paert and Rosecrans (1978), and Colpaert produced by amphetamine, methampheta- and Slangen (1982) organized symposia that mine, etc. have summarized much of our knowledge in this field. A given class of drugs such as LSD has discrete stimulus properties that can be A B distinguished from another unrelated class p~ N (~9-THC, etc). Furthermore, animals such as rats can be trained to distinguish morphine ffN Ph from 0.9 percent NaCl placebo from LSD-25, --"" d etc. Appel et al. (1982) and Appel and Rose- crans (1984) have reviewed the behavioral pharmacology of hallucinogens in animals on H+~~ H+~~ HN+ respondent (pavlovian) conditioning and op- Ph erant (instrumental) conditioning. They -==- Ph point out that the most highly specific oper- d~ ~ d ant paradigm to distinguish hallucinogens is drug discrimination. They reviewed the evi- A+ 8+ dence for a common 5-HT2 and/or halluci- nogen receptor mode of action for a variety FIGURE 2. PCP exists in four different conforma- of compounds. Rech and Commissaris (1982) tions. VOL. n. NO. J, 1see 975 additionally have provided evidence that a amine, indicating different mechanisms un- particular spectrum of activity at 5-HT2 rela- derlie the effects of acute and chronic admin- tive to 5-HT I receptor sites is characteristic istration of both drugs. of a large variety of hallucinogens. Perhaps the most important new develop- Jacobs (1984) summarized the evidence ment in the mechanisms of action of PCP that hallucinogens such as DMT, DaM, LSD- involves its effects on excitatory amino acid 25, mescaline, and psilocybin act on post- neurotransmitter systems. It has long been synaptic 5-HT receptors. All of these com- known that PCP in receptor, binding assays pounds elicit a so-called "5-HT behavioral acts on the muscarinic cholinergic receptor, syndrome" in rats which consists of head on the delta subunit of the ion channel of the weaving, tremor, rigidity, Straub tail, splayed nicotinic receptor, and on various Ca + + and hindlegs, and forepaw treading. Tolerance K + ion channels (see Domino, 1981; Ka- and cross-tolerance to these effects are ob- menka et al., 1983). Lodge et al. (1982, 1983) served which correlate with decreases (down- and Anis et al. (1983) were the first to show regulation) of 5-HT binding sites. Jacobs that arylcyclohexylamines including keta- (1984) has provided evidence that the behav- mine, PCP, tiletamine, and etoxadrol selec- ioral effects of such 5-HT acting halluci- tively reduced excitation of mammalian neu- nogens can be dissociated from their presyn- rons by NMA, but not by quisqualate and aptic actions on 5-HT neurons. kainate. Subsequently, Snell and Johnson Can the actions of LSD-25 and related in- (1985, 1986) reported that several substances dole and phenethylamine hallucinogens on with PCP-like behavioral effects inhibited the the 5-HT system be related to the actions of release of two chemical messengers, ACh and arylcyclohexylamines such as PCP or to psy- DA, evoked by MA from rat striatal slices chomotor stimulants like amphetamine? in vitro. They also showed that these effects Probably not, but there are some interesting were similar to the classic NMA antagonist, relationships and contrasts. Most 2-amino-5-phosphonovalerate, except that psychotomimetics, when given chronically, the latter produced a parallel shift to the induce tolerance. On the other hand, in ro- right in the concentration effect curve, while dents chronic amphetamine effects are PCP produced a non-parallel shift to the potentiated. In other words, chronic use pro- right, suggesting a noncompetitive interac- duces super sensitivity. Nabeshima and his tion between PCP and NMA. Koek et al. colleagues in Japan (1985) have shown that (1986) have used a behavioral analysis in ani- PCP given chronically to rats produces a mals regarding PCP and its interaction with mixed picture. The PCP-induced "5-HT like NMA. They suggest that this might be im- syndrome" is attenuated with chronic PCP portant in the mechanisms of anesthesia in- administration and shows cross-tolerance to duced by arylcyclohexylamines and related 5-MeODMT, while DA mediated behavioral substances. effects such as sniffing, rearing, or licking are enhanced in chronic PCP treated rats given Conclusions PCP or DA agonists such as apomorphine and methamphetamine. Thus, tolerance is PCP-like compounds appear to possess a observed in the 5-HT mediated but not the unique wide spectrum of pharmacological ef- DA mediated effects of PCP.
Load more

Recommended publications
  • Hallucinogens - LSD, Peyote, Psilocybin, and PCP
    Hallucinogens - LSD, Peyote, Psilocybin, and PCP Hallucinogenic compounds found in some • Psilocybin (4-phosphoryloxy-N,N- plants and mushrooms (or their extracts) dimethyltryptamine) is obtained from have been used—mostly during religious certain types of mushrooms that are rituals—for centuries. Almost all indigenous to tropical and subtropical hallucinogens contain nitrogen and are regions of South America, Mexico, and classified as alkaloids. Many hallucinogens the United States. These mushrooms have chemical structures similar to those of typically contain less than 0.5 percent natural neurotransmitters (e.g., psilocybin plus trace amounts of acetylcholine-, serotonin-, or catecholamine- psilocin, another hallucinogenic like). While the exact mechanisms by which substance. hallucinogens exert their effects remain • PCP (phencyclidine) was developed in unclear, research suggests that these drugs the 1950s as an intravenous anesthetic. work, at least partially, by temporarily Its use has since been discontinued due interfering with neurotransmitter action or to serious adverse effects. by binding to their receptor sites. This DrugFacts will discuss four common types of How Are Hallucinogens Abused? hallucinogens: The very same characteristics that led to • LSD (d-lysergic acid diethylamide) is the incorporation of hallucinogens into one of the most potent mood-changing ritualistic or spiritual traditions have also chemicals. It was discovered in 1938 led to their propagation as drugs of abuse. and is manufactured from lysergic acid, Importantly, and unlike most other drugs, which is found in ergot, a fungus that the effects of hallucinogens are highly grows on rye and other grains. variable and unreliable, producing different • Peyote is a small, spineless cactus in effects in different people at different times.
    [Show full text]
  • Hallucinogens - LSD, Peyote, Psilocybin, and PCP
    Information for Behavioral Health Providers in Primary Care Hallucinogens - LSD, Peyote, Psilocybin, and PCP What are Hallucinogens? Hallucinogenic compounds found in some plants and mushrooms (or their extracts) have been used— mostly during religious rituals—for centuries. Almost all hallucinogens contain nitrogen and are classified as alkaloids. Many hallucinogens have chemical structures similar to those of natural neurotransmitters (e.g., acetylcholine-, serotonin-, or catecholamine-like). While the exact mechanisms by which hallucinogens exert their effects remain unclear, research suggests that these drugs work, at least partially, by temporarily interfering with neurotransmitter action or by binding to their receptor sites. This InfoFacts will discuss four common types of hallucinogens: LSD (d-lysergic acid diethylamide) is one of the most potent mood-changing chemicals. It was discovered in 1938 and is manufactured from lysergic acid, which is found in ergot, a fungus that grows on rye and other grains. Peyote is a small, spineless cactus in which the principal active ingredient is mescaline. This plant has been used by natives in northern Mexico and the southwestern United States as a part of religious ceremonies. Mescaline can also be produced through chemical synthesis. Psilocybin (4-phosphoryloxy-N, N-dimethyltryptamine) is obtained from certain types of mushrooms that are indigenous to tropical and subtropical regions of South America, Mexico, and the United States. These mushrooms typically contain less than 0.5 percent psilocybin plus trace amounts of psilocin, another hallucinogenic substance. PCP (phencyclidine) was developed in the 1950s as an intravenous anesthetic. Its use has since been discontinued due to serious adverse effects. How Are Hallucinogens Abused? The very same characteristics that led to the incorporation of hallucinogens into ritualistic or spiritual traditions have also led to their propagation as drugs of abuse.
    [Show full text]
  • Hallucinogens and Dissociative Drugs
    Long-Term Effects of Hallucinogens See page 5. from the director: Research Report Series Hallucinogens and dissociative drugs — which have street names like acid, angel dust, and vitamin K — distort the way a user perceives time, motion, colors, sounds, and self. These drugs can disrupt a person’s ability to think and communicate rationally, or even to recognize reality, sometimes resulting in bizarre or dangerous behavior. Hallucinogens such as LSD, psilocybin, peyote, DMT, and ayahuasca cause HALLUCINOGENS AND emotions to swing wildly and real-world sensations to appear unreal, sometimes frightening. Dissociative drugs like PCP, DISSOCIATIVE DRUGS ketamine, dextromethorphan, and Salvia divinorum may make a user feel out of Including LSD, Psilocybin, Peyote, DMT, Ayahuasca, control and disconnected from their body PCP, Ketamine, Dextromethorphan, and Salvia and environment. In addition to their short-term effects What Are on perception and mood, hallucinogenic Hallucinogens and drugs are associated with psychotic- like episodes that can occur long after Dissociative Drugs? a person has taken the drug, and dissociative drugs can cause respiratory allucinogens are a class of drugs that cause hallucinations—profound distortions depression, heart rate abnormalities, and in a person’s perceptions of reality. Hallucinogens can be found in some plants and a withdrawal syndrome. The good news is mushrooms (or their extracts) or can be man-made, and they are commonly divided that use of hallucinogenic and dissociative Hinto two broad categories: classic hallucinogens (such as LSD) and dissociative drugs (such drugs among U.S. high school students, as PCP). When under the influence of either type of drug, people often report rapid, intense in general, has remained relatively low in emotional swings and seeing images, hearing sounds, and feeling sensations that seem real recent years.
    [Show full text]
  • Cerebellar Toxicity of Phencyclidine
    The Journal of Neuroscience, March 1995, 75(3): 2097-2108 Cerebellar Toxicity of Phencyclidine Riitta N&kki, Jari Koistinaho, Frank Ft. Sharp, and Stephen M. Sagar Department of Neurology, University of California, and Veterans Affairs Medical Center, San Francisco, California 94121 Phencyclidine (PCP), clizocilpine maleate (MK801), and oth- Phencyclidine (PCP), dizocilpine maleate (MK801), and other er NMDA antagonists are toxic to neurons in the posterior NMDA receptor antagonistshave attracted increasing attention cingulate and retrosplenial cortex. To determine if addition- becauseof their therapeutic potential. These drugs have neuro- al neurons are damaged, the distribution of microglial ac- protective properties in animal studies of focal brain ischemia, tivation and 70 kDa heat shock protein (HSP70) induction where excitotoxicity is proposedto be an important mechanism was studied following the administration of PCP and of neuronal cell death (Dalkara et al., 1990; Martinez-Arizala et MK801 to rats. PCP (10-50 mg/kg) induced microglial ac- al., 1990). Moreover, NMDA antagonists decrease neuronal tivation and neuronal HSP70 mRNA and protein expression damage and dysfunction in other pathological conditions, in- in the posterior cingulate and retrosplenial cortex. In ad- cluding hypoglycemia (Nellgard and Wieloch, 1992) and pro- dition, coronal sections of the cerebellar vermis of PCP (50 longed seizures(Church and Lodge, 1990; Faingold et al., 1993). mg/kg) treated rats contained vertical stripes of activated However, NMDA antagonists are toxic to certain neuronal microglial in the molecular layer. In the sagittal plane, the populations in the brain. Olney et al. (1989) demonstratedthat microglial activation occurred in irregularly shaped patch- the noncompetitive NMDA antagonists,PCP, MK801, and ke- es, suggesting damage to Purkinje cells.
    [Show full text]
  • Hallucinogens
    Hallucinogens What Are Hallucinogens? Hallucinogens are a diverse group of drugs that alter a person’s awareness of their surroundings as well as their thoughts and feelings. They are commonly split into two categories: classic hallucinogens (such as LSD) and dissociative drugs (such as PCP). Both types of hallucinogens can cause hallucinations, or sensations and images that seem real though they are not. Additionally, dissociative drugs can cause users to feel out of control or disconnected from their body and environment. Some hallucinogens are extracted from plants or mushrooms, and others are synthetic (human-made). Historically, people have used hallucinogens for religious or healing rituals. More recently, people report using these drugs for social or recreational purposes. Hallucinogens are a Types of Hallucinogens diverse group of drugs Classic Hallucinogens that alter perception, LSD (D-lysergic acid diethylamide) is one of the most powerful mind- thoughts, and feelings. altering chemicals. It is a clear or white odorless material made from lysergic acid, which is found in a fungus that grows on rye and other Hallucinogens are split grains. into two categories: Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) comes from certain classic hallucinogens and types of mushrooms found in tropical and subtropical regions of South dissociative drugs. America, Mexico, and the United States. Peyote (mescaline) is a small, spineless cactus with mescaline as its main People use hallucinogens ingredient. Peyote can also be synthetic. in a wide variety of ways DMT (N,N-dimethyltryptamine) is a powerful chemical found naturally in some Amazonian plants. People can also make DMT in a lab.
    [Show full text]
  • Anti-Cholinergic Alkaloids As Potential Therapeutic Agents for Alzheimer's Disease
    Indian Journal of Biochemistry & Biophysics Vol. 50, April 2013, pp. 120-125 Anti-cholinergic alkaloids as potential therapeutic agents for Alzheimer’s disease: An in silico approach Huma Naaz, Swati Singh, Veda P Pandey, Priyanka Singh and Upendra N Dwivedi* Bioinformatics Infrastructure Facility, Center of Excellence in Bioinformatics, Department of Biochemistry, University of Lucknow, Lucknow 226 007, India Received 10 September 2012; revised 25 January 2013 Alzheimer’s disease (AD), a progressive neurodegenerative disorder with many cognitive and neuropsychiatric symptoms is biochemically characterized by a significant decrease in the brain neurotransmitter acetylcholine (ACh). Plant-derived metabolites, including alkaloids have been reported to possess neuroprotective properties and are considered to be safe, thus have potential for developing effective therapeutic molecules for neurological disorders, such as AD. Therefore, in the present study, thirteen plant-derived alkaloids, namely pleiocarpine, kopsinine, pleiocarpamine (from Pleiocarpa mutica, family: Annonaceae), oliveroline, noroliveroline, liridonine, isooncodine, polyfothine, darienine (from Polyalthia longifolia, family: Apocynaceae) and eburnamine, eburnamonine, eburnamenine and geissoschizol (from Hunteria zeylanica, family: Apocynaceae) were analyzed for their anti-cholinergic action through docking with acetylcholinesterase (AChE) as target. Among the alkaloids, pleiocarpine showed promising anti-cholinergic potential, while its amino derivative showed about six-fold
    [Show full text]
  • From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia J
    REVIEW The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia J. David Jentsch, Ph.D., and Robert H. Roth, Ph.D. Administration of noncompetitive NMDA/glutamate effects of these drugs are discussed, especially with regard to receptor antagonists, such as phencyclidine (PCP) and differing profiles following single-dose and long-term ketamine, to humans induces a broad range of exposure. The neurochemical effects of NMDA receptor schizophrenic-like symptomatology, findings that have antagonist administration are argued to support a contributed to a hypoglutamatergic hypothesis of neurobiological hypothesis of schizophrenia, which includes schizophrenia. Moreover, a history of experimental pathophysiology within several neurotransmitter systems, investigations of the effects of these drugs in animals manifested in behavioral pathology. Future directions for suggests that NMDA receptor antagonists may model some the application of NMDA receptor antagonist models of behavioral symptoms of schizophrenia in nonhuman schizophrenia to preclinical and pathophysiological research subjects. In this review, the usefulness of PCP are offered. [Neuropsychopharmacology 20:201–225, administration as a potential animal model of schizophrenia 1999] © 1999 American College of is considered. To support the contention that NMDA Neuropsychopharmacology. Published by Elsevier receptor antagonist administration represents a viable Science Inc. model of schizophrenia, the behavioral and neurobiological KEY WORDS: Ketamine; Phencyclidine; Psychotomimetic; widely from the administration of purportedly psychot- Memory; Catecholamine; Schizophrenia; Prefrontal cortex; omimetic drugs (Snyder 1988; Javitt and Zukin 1991; Cognition; Dopamine; Glutamate Jentsch et al. 1998a), to perinatal insults (Lipska et al. Biological psychiatric research has seen the develop- 1993; El-Khodor and Boksa 1997; Moore and Grace ment of many putative animal models of schizophrenia.
    [Show full text]
  • Fall TNP Herbals.Pptx
    8/18/14 Introduc?on to Objecves Herbal Medicine ● Discuss history and role of psychedelic herbs Part II: Psychedelics, in medicine and illness. Legal Highs, and ● List herbs used as emerging legal and illicit Herbal Poisons drugs of abuse. ● Associate main plant and fungal families with Jason Schoneman RN, MS, AGCNS-BC representave poisonous compounds. The University of Texas at Aus?n ● Discuss clinical management of main toxic Schultes et al., 1992 compounds. Psychedelics Sacraments: spiritual tools or sacred medicine by non-Western cultures vs. Dangerous drugs of abuse vs. Research and clinical tools for mental and physical http://waynesword.palomar.edu/ww0703.htm disorders History History ● Shamanic divinaon ○ S;mulus for spirituality/religion http://orderofthesacredspiral.blogspot.com/2012/06/t- mckenna-on-psilocybin.html http://www.cosmicelk.net/Chukchidirections.htm 1 8/18/14 History History http://www.10zenmonkeys.com/2007/01/10/hallucinogenic- weapons-the-other-chemical-warfare/ http://rebloggy.com/post/love-music-hippie-psychedelic- woodstock http://fineartamerica.com/featured/misterio-profundo-pablo- amaringo.html History ● Psychotherapy ○ 20th century: un;l 1971 ● Recreaonal ○ S;mulus of U.S. cultural revolu;on http://qsciences.digi-info-broker.com http://www.uspharmacist.com/content/d/feature/c/38031/ http://en.wikipedia.org/nervous_system 2 8/18/14 Main Groups Main Groups Tryptamines LSD, Psilocybin, DMT, Ibogaine Other Ayahuasca, Fly agaric Phenethylamines MDMA, Mescaline, Myristicin Pseudo-hallucinogen Cannabis Dissociative
    [Show full text]
  • Hallucinogens & Dissociative Drugs
    ® DRUG FACT SHEET Hallucinogens & Dissociative Drugs Some effects of PCP including depression and memory loss may last six months to a year following prolonged daily use. Class of drug: Hallucinogens (most common form is LSD) Dissociative drugs (most commonly form is PCP) Main active ingredient: Hallucinogens: Lysergic acid diethylamide, mescaline, psilocybin, ibogaine Dissociative: Phencyclidine What it looks like: LSD: Clear, odorless liquid, brightly colored tablets, impregnated blotter paper, thin squares of gelatin PCP: liquid, capsules, white crystalline powder, gum There are hundreds of synthetic hallu - Street names: Lysergic acid diethylamide: LSD, Acid, Blotter, cinogens on the market today including Phencyclidine: PCP, Angel Dust, Loveboat, Wack 25I-NBOMe (N-Bomb) and 2C-I (Smiles) which have been attributed to How it is used: Both hallucinogens and dissociative drugs can be multiple deaths and significant injuries. swallowed, injected or smoked. LSD liquid and gelatin They are generally found as powders, liq - forms can be put in the eyes. PCP is often sprinkled uids, soaked into blotter paper or laced on or sprayed on cigarettes, parsley and marijuana. something edible. Both drugs are classi - fied as Schedule I substances, making Duration of high: Hallucinogens: effects begin within 30 to 90 minutes possession, distribution and manufacture and last from six to twelve hours illegal. PCP: effects begin within minutes and last for hours Withdrawal symptoms: Depression, memory loss U.S. information Effects: Physical (both) —increased heart rate and blood pressure, elevated body temperature, loss of In 2014, nearly 1.3 million appetite, loss of muscle coordination, slurred speech Americans aged 12 and older Hallucinogens reported using LSD in the past Mental —hallucinations; intensified senses; distortion year and 90,000 reported using of time, reality and environment; confusion; mood PCP in the past year.
    [Show full text]
  • Pharmacological Profile of Dizocilpine (Mk-801) And€Its
    Mil. Med. Sci. Lett. (Voj. Zdrav. Listy) 2019, 88(4), 166-179 ISSN 0372-7025 (Print) ISSN 2571-113X (Online) DOI: 10.31482/mmsl.2019.019 Since 1925 PŘEHLEDOVÝ ČLÁNEK / REVIEW ARTICLE FARMAKOLOGICKÝ PROFIL DIZOCILPINU (MK-801) A MOŽNOSTI JEHO VYUŽITÍ VE ZVÍŘECÍCH MODELECH SCHIZOFRENIE PHARMACOLOGICAL PROFILE OF DIZOCILPINE (MK-801) AND ITS POTENTIAL USE IN ANIMAL MODEL OF SCHIZOPHRENIA Jan Konečný 1,2, Radomír Jůza 3, Ondřej Soukup 1,2, Jan Korábečný 1,2,3 1 Katedra toxikologie a vojenské farmacie, Fakulta vojenského zdravotnictví, Třebešská 1575, 500 02, Hradec Králové, Česká republika 2 Centrum biomedicínského výzkumu, Fakultní nemocnice Hradec Králové, Sokolská 581, 500 05 Hradec Králové, Česká republika 3 Národní ústav duševního zdraví, Topolová 748, 250 67 Klecany, Česká republika Přijato 19. července 2019. Akceptováno 5. září 2019. Zveřejněno 6. prosince 2019. Souhrn N-Methyl-D-aspartátový (NMDA) receptor patří do skupiny glutamátových receptorů, které se dále dělí na ionotropní a metabotropní. V CNS má vliv na synaptickou plasticitu a rozvoj neuronálních synapsí. Ionotropní NMDA receptory jsou aktivovány glutamátem, díky čemuž proudí pozitivně nabité ionty skrz membránu po svém koncentračním gradientu. Nicméně nadměrné hladiny glutamátu působí excitotoxicky díky vysokým intracelulárním hladinám Ca2+ a mohou vést k buněčné smrti neuronů pozorované např. u neurodegenerativních onemocnění. Antagonisté NMDA receptorů, mezi které patří například dizocilpin, ovlivňují prostupnost NMDA receptoru a zamezují tak vstupu iontů Ca2+ do buňky. Dizocilpin působí jako nekompetitivní antagonista NMDA receptoru, má antikonvulzivní a anestetické účinky. Jeho terapeutické použití u lidí není vhodné z důvodu výskytu četných vedlejších účinků, experimentálně je však využíván jako farmakologicky indukovaný animální model schizofrenie.
    [Show full text]
  • Phencyclidine: an Update
    Phencyclidine: An Update U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse and Mental Health Administration Phencyclidine: An Update Editor: Doris H. Clouet, Ph.D. Division of Preclinical Research National Institute on Drug Abuse and New York State Division of Substance Abuse Services NIDA Research Monograph 64 1986 DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administratlon National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20657 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 NIDA Research Monographs are prepared by the research divisions of the National lnstitute on Drug Abuse and published by its Office of Science The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. SIDNEY COHEN, M.D. Temple University School of Medicine Los Angeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic lnstitute National Federation of Parents for Troy, New York Drug Free Youth RICHARD E. BELLEVILLE, Ph.D. Omaha, Nebraska NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTEMAN Langley Porter Neuropsychiatric lnstitute Alcohol and Drug Problems Association San Francisco, California of North America Washington, D.C. DENISE KANDEL, Ph.D GILBERT J. BOTV N, Ph.D. College of Physicians and Surgeons of Cornell University Medical College Columbia University New York, New York New York, New York JOSEPH V.
    [Show full text]
  • Ce4less.Com Ce4less.Com Ce4less.Com Ce4less.Com Ce4less.Com Ce4less.Com Ce4less.Com
    Hallucinogens And Dissociative Drug Use And Addiction Introduction Hallucinogens are a diverse group of drugs that cause alterations in perception, thought, or mood. This heterogeneous group has compounds with different chemical structures, different mechanisms of action, and different adverse effects. Despite their description, most hallucinogens do not consistently cause hallucinations. The drugs are more likely to cause changes in mood or in thought than actual hallucinations. Hallucinogenic substances that form naturally have been used worldwide for millennia to induce altered states for religious or spiritual purposes. While these practices still exist, the more common use of hallucinogens today involves the recreational use of synthetic hallucinogens. Hallucinogen And Dissociative Drug Toxicity Hallucinogens comprise a collection of compounds that are used to induce hallucinations or alterations of consciousness. Hallucinogens are drugs that cause alteration of visual, auditory, or tactile perceptions; they are also referred to as a class of drugs that cause alteration of thought and emotion. Hallucinogens disrupt a person’s ability to think and communicate effectively. Hallucinations are defined as false sensations that have no basis in reality: The sensory experience is not actually there. The term “hallucinogen” is slightly misleading because hallucinogens do not consistently cause hallucinations. 1 ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com How hallucinogens cause alterations in a person’s sensory experience is not entirely understood. Hallucinogens work, at least in part, by disrupting communication between neurotransmitter systems throughout the body including those that regulate sleep, hunger, sexual behavior and muscle control. Patients under the influence of hallucinogens may show a wide range of unusual and often sudden, volatile behaviors with the potential to rapidly fluctuate from a relaxed, euphoric state to one of extreme agitation and aggression.
    [Show full text]